What is MDxHealth SA (MDXH) stock price today?

MDxHealth SA (MDXH) is currently trading at $0.59, up 1.58% today.

What is MDXH P/E ratio?

MDxHealth SA's P/E ratio is -1.02. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is MDXH return on equity (ROE)?

MDxHealth SA's return on equity (ROE) is 142.63%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

What is MDxHealth SA's market cap?

MDxHealth SA has a market capitalization of $30.29M.

NASDAQ · Medical - Diagnostics & Research

MDxHealth SA (MDXH) Stock

$0.59 +1.58% NASDAQ: MDXH Healthcare

Valuation

Metric	Value
Price	$0.59
Market Cap	$30.29M
P/E Ratio	-1.02
P/B Ratio	-1.03
P/S Ratio	0.38
EPS (TTM)	$-0.67
52-Week High	$5.33
52-Week Low	$0.40
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	142.63%
ROA	-22.94%
ROCE	-17.60%
Gross Margin	-13.89%
Operating Margin	-13.89%
Net Margin	-37.02%
Debt/Equity	-3.48
Current Ratio	1.06

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$22.0M	$37.0M	$70.0M	$90.0M	$108.0M
Operating Profit	$-27.0M	$-38.0M	$-27.0M	$-25.0M	$-15.0M
Net Profit	$-29.0M	$-44.0M	$-43.0M	$-38.0M	$-34.0M
EPS	$-2.38	$-2.78	$-1.66	$-1.16	$-0.67
Op Margin	-120.7%	-102.3%	-38.9%	-27.4%	-14.3%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$75.0M	$119.0M	$129.0M	$157.0M	$148.0M
Total Liabilities	$28.0M	$110.0M	$122.0M	$142.0M	$160.0M
Cash	$58.0M	$16.0M	$22.0M	$47.0M	$29.0M
Borrowings	$16.0M	$40.0M	$41.0M	$60.0M	$95.0M

Latest News

Mdxhealth to Release Second Quarter 2026 Financial Results on August 13 GlobeNewswire · Jul 30, 2026 Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Listed Securities Deficiency GlobeNewswire · Jul 24, 2026 MDxHealth Gets Nasdaq Non-Compliance Notice MT Newswires · Jul 2, 2026 Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency GlobeNewswire · Jul 2, 2026 Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized Controlled Trial GlobeNewswire · Jun 29, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-23.0M	$-34.0M	$-21.0M	$-19.0M	$-10.0M
Investing Cash Flow	$-2.0M	$-33.0M	$-9.0M	$-4.0M	$-21.0M
Financing Cash Flow	$-1.0M	$-1.0M	$-4.0M	$-8.0M	$-9.0M
Net Cash Flow	$43.0M	$-43.0M	$7.0M	$24.0M	$-18.0M
Free Cash Flow	$-23.0M	$-38.0M	$-27.0M	$-21.0M	$-12.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	-0.03
EV / EBITDA	-15.16
FCF Yield	-18.06%
Quick Ratio	0.98
Interest Coverage	-1.15
Return 1Y	-79.86%
Return 3Y	-87.60%
Return 5Y	—

Ownership

Insiders Held11.13%

Institutions Held38.04%

Institutions Float Held42.81%

Institutional Holder	Shares	Report Date
Bleichroeder LP	7,378,333	2026-03-31
AWM Investment Company, Inc.	5,221,282	2026-03-31
MVM Partners, LLC	4,700,457	2026-03-31
Samjo Management, LLC	1,449,450	2026-03-31
Perkins Capital Management, Inc.	1,411,891	2026-06-30

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ACRSAclaris Therapeutics, Inc.	$3.83	+1.06%	-8.88	$534.91M	0.00%
ASMBAssembly Biosciences, Inc.	$23.53	+3.11%	40.98	$466.30M	0.00%
IMRXImmuneering Corporation	$3.94	+5.35%	-3.91	$143.03M	0.00%
NEONeoGenomics, Inc.	$16.35	+2.06%	-9.31	$420.11M	0.00%
QTRXQuanterix Corporation	$3.28	+2.18%	-1.38	$154.51M	0.00%

About MDxHealth SA

MDxHealth SA is led by CEO Michael K. McGarrity, employs 312 people, headquartered in BE, publicly traded since 2021.

MDxHealth SA (MDXH) stock trades at $0.59 with a market capitalization of $30.29M. The stock is valued at a price-to-earnings (P/E) ratio of -1.02, price-to-book of -1.03, price-to-sales of 0.38. Over the past 52 weeks the stock has ranged between $0.40 and $5.33, and currently trades 88.9% below its 52-week high.

On profitability, MDxHealth SA generates a return on equity (ROE) of 142.63% — well above the market average, a sign of a high-quality business, return on capital employed of -17.60%, an operating margin of -13.89%, a net profit margin of -37.02%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides